Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.

UNLABELLED To assess the mechanisms of the insulin resistance in human obesity, we have determined, using a modification of the euglycemic glucose clamp technique, the shape of the in vivo insulin-glucose disposal dose-response curves in 7 control and 13 obese human subjects. Each subject had at least three euglycemic studies performed at insulin infusion rates of 15, 40, 120, 240, or 1,200 mU/M2/min. The glucose disposal rate was decreased in all obese subjects compared with controls (101 +/- 16 vs. 186 +/- 16 mg/M2/min) during the 40 mU/M2/min insulin infusion. The mean dose-response curve for the obese subjects was displaced to the right, i.e., the half-maximally effective insulin concentration was 270 +/- 27 microU/ml for the obese compared with 130 +/- 10 microU/ml for controls. In nine of the obese subjects, the dose-response curves were shifted to the right, and maximal glucose disposal rates (at a maximally effective insulin concentration) were markedly decreased, indicating both a receptor and a postreceptor defect. On the other hand, four obese patients had right-shifted dose-response curves but reached normal maximal glucose disposal rates, consistent with decreased insulin receptors as the only abnormality. When the individual data were analyzed, it was found that the lease hyperinsulinemic, least insulin-resistant patients displayed only the receptor defect, whereas those with the greatest hyperinsulinemia exhibited the largest post-receptor defect, suggesting a continuous spectrum of defects as one advances from mild to severe insulin resistance. When insulin's ability to suppress hepatic glucose output was assessed, hyperinsulinemia produced total suppresssion in all subjects. The dose-response curve for the obese subjects was shifted to the right, indicating a defect in insulin receptors. Insulin binding to isolated adipocytes obtained from the obese subjects was decreased, and a highly significant inverse linear relationship was demonstrated between insulin binding and the serum insulin concentration required for halfmaximal stimulation of glucose disposal. IN CONCLUSION (a) decreased cellular insulin receptors contribute to the insulin resistance associated with human obesity in all subjects; (b) in the least hyperinsulinemic, insulin-resistant patients, decreased insulin receptors are the sole defect, whereas in the more hyperinsulinemic, insulin-resistant patients, the insulin resistance is the result of a combination of receptor and postreceptor abnormalities; (c) all obese patients were insensitive to insulin's suppressive effects on hepatic glucose output; this was entirely the result of decreased insulin receptors; no postreceptor defect in this insulin effect was demonstrated.

[1]  G. Reaven,et al.  Relationship between in vivo insulin resistance and decreased insulin receptors in obese man. , 1979, The Journal of clinical endocrinology and metabolism.

[2]  C. Kahn.  Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. , 1978, Metabolism: clinical and experimental.

[3]  R. DeFronzo,et al.  Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Cherrington,et al.  Effect of glucagon on glucose production during insulin deficiency in the dog. , 1978, The Journal of clinical investigation.

[5]  A. Cherrington,et al.  Gluconeogenesis: methodological approaches in vivo. , 1977, Federation proceedings.

[6]  R. DeFronzo,et al.  Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Olefsky.  The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes , 1976, Diabetes.

[8]  C. Kahn,et al.  Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting. , 1976, The Journal of clinical investigation.

[9]  J. Roth,et al.  Cooperativity in ligand binding: a new graphic analysis. , 1975, Biochemical and biophysical research communications.

[10]  M Berman,et al.  Insulin control of glucose metabolism in man: a new kinetic analysis. , 1975, The Journal of clinical investigation.

[11]  J. Roth,et al.  Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction. , 1975, The Journal of clinical investigation.

[12]  M Berman,et al.  A model of the kinetics of insulin in man. , 1974, The Journal of clinical investigation.

[13]  L. Frohman,et al.  Studies of insulin sensitivity in vivo in weanling rats with hypothalamic obesity. , 1972, Metabolism: clinical and experimental.

[14]  J. Holm,et al.  The Glucose Uptake of Human Adipose Tissue in Obesity , 1971, European journal of clinical investigation.

[15]  B. Desbuquois,et al.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. , 1971, The Journal of clinical endocrinology and metabolism.

[16]  T. Kôno,et al.  The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin. Studies with intact and trypsin-treated fat cells. , 1971, The Journal of biological chemistry.

[17]  J. Dougherty,et al.  The effect of insulin upon glucose metabolism by adipose cells of different size. Influence of cell lipid and protein content, age, and nutritional state. , 1971, The Journal of clinical investigation.

[18]  P. Björntorp,et al.  Effects of feeding states on lipid radioactivity in liver, muscle and adipose tissue after injection of labelled glucose in the rat. , 1970, Acta physiologica Scandinavica.

[19]  G F Cahill,et al.  Starvation in man. , 1970, The New England journal of medicine.

[20]  M. Vranic,et al.  Matched rates of insulin infusion and secretion and concurrent tracer-determined rates of glucose appearance and disappearance in fasting dogs. , 1968, Canadian journal of physiology and pharmacology.

[21]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[22]  S. Fajans,et al.  THE EARLY RECOGNITION OF DIABETES MELLITUS * , 1959, Annals of the New York Academy of Sciences.

[23]  P. Bjurulf.  Atherosclerosis and body-build with special reference to size and number of subcutaneous fat cells. , 1959, Acta medica Scandinavica. Supplementum.